Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
There has been dramatic growth in the number of intravitreal injections performed annually. This paper features expert panel consensus regarding the use of intravitreal injections and serves as an ...
We report a case of posterior lens nucleus displacement following an intravitreal injection of bevacizumab (IVB). To the best of our knowledge this complication has not been previously reported. A ...
Please provide your email address to receive an email when new articles are posted on . I believe intravitreal injections are best performed in the office for many reasons. First of all, it is safe.
The use of intravitreal vascular endothelial growth factor (VEGF) inhibitor medications has widened considerably to include indications affecting females of reproductive age. All our patients were ...
Povidone-iodine is the most commonly used antiseptic for the ocular surface. It is also used for the prophylaxis of infection in eyes undergoing intravitreal injection. Published endophthalmitis rates ...
An intravitreal implant (OTX-TKI) containing the tyrosine kinase inhibitor axitinib (Inlyta) was well tolerated and significantly reduced injection frequency by nearly 90% in patients with wet ...
A low risk of adverse safety outcomes was observed in anti–vascular endothelial growth factor (VEGF) intravitreal injections performed in office-based and operating room settings, with a higher rate ...
Patients completed a questionnaire that assessed the impact of intravitreal injections on quality of life This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, ...
Significantly fewer patients in the fluocinolone acetonide intravitreal implant group experienced recurrence of uveitis at 6 months compared with the sham group. The Food and Drug Administration (FDA) ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN ANTONIO -- ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results